Antibiotic replay

Frazier Healthcare Ventures is betting the team at Kalidex Pharmaceuticals Inc. can build a third successful antibiotic company.

Kalidex, which emerged from stealth mode last week, quietly raised $45 million in a series A round last year. Frazier led the round, with participation from Domain Associates; Canaan Partners; New Leaf Venture Partners; MPM Capital; and OrbiMed...